A recent survey found roughly three million Canadians are taking GLP-1 medications like Ozempic and Mounjaro. The drugs can reduce appetite and cravings, and could also affect the body’s fat and muscle stores. Registered dietitian and Obesity Canada's Jennifer Brown says people on GLP-1 drugs may need to be more intentional about what they eat — from protein and micronutrients to fibre and fluids.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Researchers in Canada and around the world are exploring ways stem cells could help treat conditions like diabetes, Parkinson's and heart disease, but the hype sometimes outpaces the science. Neurosurgeon and researcher Dr. Sheila Singh of McMaster University and King’s College London explains what stem cells can—and can’t—do, including why they’re no miracle cure for aging.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.

Lung cancer is the deadliest cancer in Canada, and a growing number of never-smokers are getting diagnosed. Dr. Nicole Ezer, director of McGill University Health Centre's lung cancer screening centre, explains why this is happening and how workplace and environmental exposures may be contributing.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.